Traditional Dysphagia Therapy Improves Swallowing Function in MS Patients, Pilot Study Shows
Rehabilitation using traditional dysphagia therapy improved swallowing function in multiple sclerosis patients with dysphagia, a pilot study shows.
The research article with that finding, “The effect of traditional dysphagia therapy on the swallowing function in patients with Multiple Sclerosis: A pilot double-blinded randomized controlled trial” was published in the Journal of Bodywork and Movement Therapies.
Traditional dysphagia therapy (TDT) is a potential rehabilitation strategy for multiple sclerosis (MS) patients with dysphagia (difficulty swallowing). While TDT may improve dysphagia, medical data is lacking about its effect on swallowing function in MS patients.
That is why researchers from the Tehran University of Medical Sciences and the Iran University of Medical Sciences, in Iran, investigated the effects of TDT on dysphagia in MS patients.
“To the best of our knowledge, this pilot study was the first randomized clinical trial to date investigating the effects of the traditional dysphagia therapy on the swallowing function in MS patients with dysphagia,” the researchers wrote.
The study was a randomized, double-blinded, trial, which means study information was withheld from participants and examiners to avoid influencing the results.
A total of 20 MS patients were enrolled, with a mean age of 43.7 years, and mean disease duration of 6.6 years. Eleven patients (55%) had relapsing-remitting MS (RRMS), three patients (15%) had primary progressive MS (PPMS), and six patients (30%) had secondary progressive MS (SPMS).
Results showed that the patients’ swallowing abilities after study completion were improved in both groups, although the improvement in MASA scores was different. In the TDT group, MASA scores progressively improved, increasing at every time point analyzed; whereas in the control group, MASA scores improved at the end of nine sessions but didn’t really change after 18 sessions, and began to decrease six weeks after treatment ended.
Overall, the TDT group showed more improvements in swallowing ability measured by the MASA score at an increased rate across all times analyzed, compared to the control group.
Dysphagia decreased in both groups, given that PAS and PRRS scores were decreased six weeks after treatment completion. However, the reduction in PAS and PRRS scores (meaning decreased swallowing difficulty) in the TDT group was greater than in the control group — a reduction of 3.18 and 2.26 points in PAS and PRSS in the TDT group, compared with a 2.75 and 2.06 reduction, respectively, in the control group.
The findings indicate that although swallowing function becomes safer after treatment in both groups, TDT techniques seem to be better at reducing penetration, aspiration, and pharyngeal residue than the usual care techniques.
“The findings of the current study [imply] that the traditional dysphagia therapy techniques may improve the underlying pathophysiology, mainly weakness and reduced endurance, sensory thresholds, tone, timing, and coordination,” in MS patients with dysphagia, researchers concluded.
Nonetheless, the team emphasized that future studies, with larger sample sizes, are needed to confirm these results.
